CA-platin significantly inhibited the tumor growth in the HepG2 xenograft model in vivo (Table 2); however, the hybrid was less effective than cisplatin given as a single agent and cisplatin given to mice simultaneously with CA-4 [86]. This evidence concerns the gene CA4 and neoplasm.